Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Syria’s civil war – Another grim anniversary after 7 years
03/09/2018. After seven years, the unabated violence of the Syrian civil war continues to cause monumental suffering for millions of civilians in the Middle East.
Yemen: UN envoy urges Security Council to pressure warring parties to discuss peace proposal
03/30/2017. “The only real way to prevent a worsening of the situation is to reach a peaceful resolution”
Sweating the small stuff at the World Humanitarian Summit
05/26/2016. Meetings can seem a long way removed from the day-to-day challenges facing many in the aid world.
